As of 2025-05-18, the EV/EBITDA ratio of Moberg Pharma AB (publ) (MOB.ST) is -5.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOB.ST's latest enterprise value is 121.19 mil SEK. MOB.ST's TTM EBITDA according to its financial statements is -23.51 mil SEK. Dividing these 2 quantities gives us the above MOB.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 13.0x | 7.3x |
| Forward P/E multiples | 5.2x - 8.2x | 6.8x |
| Fair Price | 3.48 - 1.99 | 2.59 |
| Upside | -59.4% - -76.7% | -69.8% |
| Date | EV/EBITDA |
| 2025-05-16 | -5.15 |
| 2025-05-15 | -4.64 |
| 2025-05-14 | -4.28 |
| 2025-05-13 | -3.08 |
| 2025-05-12 | -2.67 |
| 2025-05-09 | -2.77 |
| 2025-05-08 | -2.63 |
| 2025-05-07 | -2.84 |
| 2025-05-06 | -2.83 |
| 2025-05-05 | -3.28 |
| 2025-05-02 | -3.66 |
| 2025-04-30 | -3.69 |
| 2025-04-29 | -3.38 |
| 2025-04-28 | -3.79 |
| 2025-04-25 | -4.21 |
| 2025-04-24 | -3.81 |
| 2025-04-23 | -4.22 |
| 2025-04-22 | -3.78 |
| 2025-04-17 | -3.38 |
| 2025-04-16 | -3.61 |
| 2025-04-15 | -3.73 |
| 2025-04-14 | -3.46 |
| 2025-04-11 | -2.11 |
| 2025-04-10 | -2.37 |
| 2025-04-09 | -2.21 |
| 2025-04-08 | -2.36 |
| 2025-04-07 | -1.88 |
| 2025-04-04 | -2.47 |
| 2025-04-03 | -3.58 |
| 2025-04-02 | -3.50 |
| 2025-04-01 | -3.79 |
| 2025-03-31 | -3.80 |
| 2025-03-28 | -3.83 |
| 2025-03-27 | -3.73 |
| 2025-03-26 | -3.83 |
| 2025-03-25 | -4.70 |
| 2025-03-24 | -3.23 |
| 2025-03-21 | -3.60 |
| 2025-03-20 | -4.01 |
| 2025-03-19 | -3.63 |
| 2025-03-18 | -3.48 |
| 2025-03-17 | -3.86 |
| 2025-03-14 | -3.91 |
| 2025-03-13 | -3.89 |
| 2025-03-12 | -4.15 |
| 2025-03-11 | -4.28 |
| 2025-03-10 | -4.52 |
| 2025-03-07 | -5.67 |
| 2025-03-06 | -5.60 |
| 2025-03-05 | -5.71 |